The Exclusion Criteria for Stone Recurrence

There's a number of exclusion criteria. Participants could not have been on pharmacologic prevention for stone recurrence within three months prior to randomization. Carbonic and hydrogen inhibitors, xanthinoxidase inhibitors, alkali therapy was not allowed. Active vitamin D, calcium supplements, bisphosphonates, dinosumab, terraparatide, and glucocorticoids were prohibited.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app